Sherbrooke Park Advisers’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,366
Closed -$1.11M 277
2025
Q3
$1.11M Buy
16,366
+5,867
+56% +$425K 0.51% 20
2025
Q2
$782K Buy
10,499
+529
+5% +$35.2K 0.34% 78
2025
Q1
$627K Sell
9,970
-915
-8% -$56.6K 0.29% 85
2024
Q4
$620K Buy
+10,885
New +$644K 0.2% 147
2024
Q3
Sell
-34,238
Closed -$1.85M 970
2024
Q2
$1.85M Buy
34,238
+13,280
+63% +$731K 0.32% 42
2024
Q1
$1.21M Buy
20,958
+9,880
+89% +$510K 0.24% 114
2023
Q4
$531K Sell
11,078
-73
-0.7% -$3.48K 0.25% 150
2023
Q3
$570K Buy
+11,151
New +$591K 0.18% 212
2023
Q1
Sell
-11,300
Closed -$664K 210
2022
Q4
$664K Buy
+11,300
New +$715K 0.49% 68

Other funds holding CTVA

Sherbrooke Park Advisers's CTVA Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Corteva (CTVA) in Q4 2025, closing a stake of 16,366 shares — an estimated $1.11M sold.

Sherbrooke Park Advisers first reported a position in CTVA in Q4 2022 and held it in 9 quarters. The position peaked at $1.85M in Q2 2024. 1,423 funds tracked by Wall St. Rank hold CTVA as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Corteva position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 16,366 Corteva shares in Q4 2025, an estimated $1.11M.
  • Sherbrooke Park Advisers first reported a position in Corteva in Q4 2022 and held it in 9 quarters.
  • Sherbrooke Park Advisers's Corteva position peaked at $1.85M in Q2 2024.
  • 1,423 funds tracked by Wall St. Rank held Corteva as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.